Nifty
Sensex
:
:
23477.80
74902.59
46.30 (0.20%)
138.36 (0.19%)

Trading

Rating :
38/99

BSE: 524743 | NSE: FISCHER

34.78
09-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  36
  •  36.01
  •  34.5
  •  35.56
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  669109
  •  23386703.78
  •  124.7
  •  31.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,436.32
  • 81.69
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,483.63
  • N/A
  • 5.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.15%
  • 4.42%
  • 24.33%
  • FII
  • DII
  • Others
  • 5.48%
  • 0.00%
  • 3.62%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 98.36
  • 750.40

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.00
  • 195.15
  • 178.32

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 36.36
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.28
  • 18.28
  • 18.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 584.30
  • 584.30
  • 584.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
81.92
23.45
249.34%
97.73
49.17
98.76%
101.09
11.75
760.34%
86.30
39.66
117.60%
Expenses
70.67
19.34
265.41%
96.73
46.67
107.26%
79.53
11.25
606.93%
70.05
39.16
78.88%
EBITDA
11.25
4.10
174.39%
1.00
2.50
-60.00%
21.56
0.50
4,212.00%
16.25
0.49
3,216.33%
EBIDTM
13.73%
17.50%
1.03%
5.09%
21.33%
4.23%
18.84%
1.25%
Other Income
1.48
7.47
-80.19%
1.28
0.15
753.33%
1.09
0.38
186.84%
2.48
0.22
1,027.27%
Interest
3.54
0.66
436.36%
3.61
0.23
1,469.57%
0.64
0.07
814.29%
0.92
0.05
1,740.00%
Depreciation
1.36
0.77
76.62%
0.93
0.51
82.35%
0.77
0.56
37.50%
0.51
0.29
75.86%
PBT
7.83
10.14
-22.78%
-2.25
1.91
-
21.24
0.25
8,396.00%
17.30
0.38
4,452.63%
Tax
4.04
5.17
-21.86%
4.86
0.50
872.00%
1.95
0.42
364.29%
3.37
-0.08
-
PAT
3.79
4.97
-23.74%
-7.11
1.42
-
19.29
-0.17
-
13.94
0.46
2,930.43%
PATM
4.63%
21.20%
-7.27%
2.88%
19.08%
-1.42%
16.15%
1.17%
EPS
0.06
0.07
-14.29%
-0.11
0.02
-
0.30
-0.01
-
0.21
0.01
2,000.00%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Net Sales
367.04
110.70
20.98
0.18
Net Sales Growth
195.93%
427.65%
11555.56%
 
Cost Of Goods Sold
188.24
91.59
16.46
0.00
Gross Profit
178.80
19.11
4.53
0.18
GP Margin
48.71%
17.26%
21.59%
100%
Total Expenditure
316.98
107.36
19.12
0.16
Power & Fuel Cost
-
0.87
0.19
0.00
% Of Sales
-
0.79%
0.91%
0%
Employee Cost
-
2.58
0.38
0.05
% Of Sales
-
2.33%
1.81%
27.78%
Manufacturing Exp.
-
0.25
0.00
0.00
% Of Sales
-
0.23%
0%
0%
General & Admin Exp.
-
9.06
1.93
0.11
% Of Sales
-
8.18%
9.20%
61.11%
Selling & Distn. Exp.
-
1.19
0.06
0.00
% Of Sales
-
1.07%
0.29%
0%
Miscellaneous Exp.
-
1.82
0.11
0.00
% Of Sales
-
1.64%
0.52%
0%
EBITDA
50.06
3.34
1.86
0.02
EBITDA Margin
13.64%
3.02%
8.87%
11.11%
Other Income
6.33
1.49
0.50
0.00
Interest
8.71
0.49
0.07
0.02
Depreciation
3.57
1.63
0.18
0.00
PBT
44.12
2.71
2.11
0.00
Tax
14.22
1.01
0.27
0.04
Tax Rate
32.23%
37.27%
12.80%
0.00%
PAT
29.91
1.48
1.38
-0.04
PAT before Minority Interest
29.91
1.21
1.84
-0.04
Minority Interest
0.00
0.27
-0.46
0.00
PAT Margin
8.15%
1.34%
6.58%
-22.22%
PAT Growth
347.75%
7.25%
-
 
EPS
0.46
0.02
0.02
0.00

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Shareholder's Funds
337.52
81.11
-0.27
Share Capital
63.80
53.50
0.17
Total Reserves
243.50
26.74
-0.44
Non-Current Liabilities
17.30
1.38
0.47
Secured Loans
0.00
0.00
0.57
Unsecured Loans
0.26
0.00
0.00
Long Term Provisions
0.09
0.00
0.00
Current Liabilities
101.82
3.83
0.05
Trade Payables
20.65
2.16
0.01
Other Current Liabilities
20.23
1.67
0.03
Short Term Borrowings
60.14
0.00
0.00
Short Term Provisions
0.80
0.01
0.00
Total Liabilities
456.98
86.32
0.25
Net Block
23.88
14.71
0.00
Gross Block
26.72
15.93
0.00
Accumulated Depreciation
2.84
1.22
0.00
Non Current Assets
91.70
15.92
0.00
Capital Work in Progress
1.11
0.00
0.00
Non Current Investment
10.77
1.21
0.00
Long Term Loans & Adv.
21.94
0.00
0.00
Other Non Current Assets
34.00
0.00
0.00
Current Assets
365.29
70.41
0.25
Current Investments
0.00
0.00
0.00
Inventories
9.16
4.48
0.00
Sundry Debtors
76.07
22.87
0.17
Cash & Bank
251.36
37.95
0.04
Other Current Assets
28.70
0.45
0.00
Short Term Loans & Adv.
25.95
4.66
0.04
Net Current Assets
263.47
66.57
0.20
Total Assets
456.99
86.33
0.25

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Cash From Operating Activity
-86.74
-7.35
0.00
PBT
2.22
2.11
0.00
Adjustment
2.10
0.25
0.00
Changes in Working Capital
-90.14
-9.66
0.00
Cash after chg. in Working capital
-85.82
-7.30
0.00
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.92
-0.05
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-124.88
-31.39
0.00
Net Fixed Assets
-0.78
-0.01
Net Investments
-253.08
-41.28
Others
128.98
9.90
Cash from Financing Activity
314.92
37.06
0.00
Net Cash Inflow / Outflow
103.31
-1.68
0.00
Opening Cash & Equivalents
0.95
0.04
0.00
Closing Cash & Equivalent
104.26
0.95
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Book Value (Rs.)
4.82
1.50
-15.47
ROA
0.44%
4.25%
-14.72%
ROE
0.62%
4.60%
0.00%
ROCE
1.13%
5.35%
4.97%
Fixed Asset Turnover
5.19
1.32
0.00
Receivable days
163.11
200.41
346.90
Inventory Days
22.49
77.86
0.00
Payable days
45.45
24.06
0.00
Cash Conversion Cycle
140.14
254.20
346.90
Total Debt/Equity
0.20
0.00
-2.15
Interest Cover
5.50
32.23
0.92

News Update:


  • Fischer Medical Ventures’ arm wins Catanduanes Integrated Digital Healthcare Project
    25th Aug 2026, 14:11 PM

    The Catanduanes rollout also demonstrates how digital technology can support the objectives of the Philippines’ Universal Health Care program

    Read More
  • Fischer Medical Ventures’ arm enters into partnership with Parul Sevashram Hospital
    31st Jul 2026, 14:51 PM

    The partnership aims to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.